You can find the annual or quarterly income statement of Connect Biopharma Holdings Ltd here for insights into the performance and operational efficiency of Connect Biopharma Holdings Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q1

FY2024H1

FY2023H1

Total revenue

--169.00K

--0.00

--16.00K

--48.00K

----

--24.12M

--0.00

Revenue

--169.00K

--0.00

--16.00K

--48.00K

----

--24.12M

--0.00

Operating expenses

72.76%19.78M

--15.53M

--17.69M

--13.47M

-9.39%11.45M

--12.63M

-49.60%15.54M

--30.84M

R&D expenses

126.59%15.03M

--11.28M

--11.11M

--8.77M

-23.43%6.63M

--8.66M

-50.02%13.32M

--26.64M

Depreciation, depletion, and amortization

-5.20%164.00K

--181.00K

--179.00K

--171.00K

5.49%173.00K

--164.00K

-6.11%476.00K

--507.00K

Other operating expenses

----

-55.44%-6.05M

---3.89M

Operating profit

-71.29%-19.61M

---15.53M

---17.68M

---13.42M

9.39%-11.45M

---12.63M

127.79%8.57M

---30.84M

Net non-operating interest income (expenses)

Non-operating interest income

-63.89%260.00K

--384.00K

--545.00K

--619.00K

-42.26%720.00K

--1.25M

-75.91%411.00K

--1.71M

Non-operating interest expense

----

0.00%10.00K

--10.00K

Gains from sale of securities

----

0.00%-481.00K

---481.00K

Special income (expenses)

----

0.00%-782.00K

---782.00K

Other non-operating income (expenses)

-100.59%-3.00K

--60.00K

---7.00K

---39.00K

-81.31%509.00K

--2.72M

----

Income before tax

-89.37%-19.35M

---15.08M

---17.14M

---12.84M

-17.95%-10.22M

---8.66M

125.35%7.71M

---30.41M

Income tax

-11.11%48.00K

--27.00K

--61.00K

--55.00K

80.00%54.00K

--30.00K

-6.25%60.00K

--64.00K

Income after tax

-88.84%-19.40M

---15.11M

---17.20M

---12.90M

-18.16%-10.27M

---8.69M

125.10%7.65M

---30.47M

Net income from continuous operations

----

---15.11M

---17.20M

---12.90M

-18.16%-10.27M

---8.69M

125.10%7.65M

---30.47M

Net income attributable to controlling interests

----

---15.11M

---17.20M

---12.90M

-18.16%-10.27M

---8.69M

125.10%7.65M

---30.47M

Net income attributable to common shareholders

----

---15.11M

---17.20M

---12.90M

-18.16%-10.27M

---8.69M

125.10%7.65M

---30.47M

Basic earnings per share

-83.21%-0.34

---0.27

---0.31

---0.23

-17.63%-0.19

---0.16

125.06%0.14

---0.55

Diluted earnings per share

-83.21%-0.34

---0.27

---0.31

---0.23

-17.63%-0.19

---0.16

124.87%0.14

---0.55

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

